DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Sevelamer Carbonate is a drug marketed by Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Impax, Amneal Pharms Co, Anxin, Impax Labs Inc, Invagen Pharms, Mylan, Rising, Twi Pharms, and Zydus Pharms. and is included in thirteen NDAs.
The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.
A generic version of SEVELAMER CARBONATE was approved as sevelamer carbonate by AUROBINDO PHARMA LTD on June 13th, 2017.
Summary for SEVELAMER CARBONATE
|Suppliers / Packagers:||17|
|Bulk Api Vendors:||16|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for SEVELAMER CARBONATE|
|What excipients (inactive ingredients) are in SEVELAMER CARBONATE?||SEVELAMER CARBONATE excipients list|
|DailyMed Link:||SEVELAMER CARBONATE at DailyMed|
Recent Clinical Trials for SEVELAMER CARBONATE
Identify potential brand extensions & 505(b)(2) entrants
|Shanghai Alebund Pharmaceuticals Limited||Phase 2|
|Akebia Therapeutics||Phase 1|
|Shandong Weigao Panion Pharmaceutical Co. Ltd.||Phase 3|